Targeted disruption ofTraf5gene causes defects in CD40- and CD27-mediated lymphocyte activation

Mice, Knockout TNF Receptor-Associated Factor 5 Membrane Glycoproteins CD40 Ligand JNK Mitogen-Activated Protein Kinases NF-kappa B Proteins Lymphocyte Activation Tumor Necrosis Factor Receptor Superfamily, Member 7 Enzyme Activation Mice 03 medical and health sciences 0302 clinical medicine Calcium-Calmodulin-Dependent Protein Kinases Animals CD40 Antigens Mitogen-Activated Protein Kinases
DOI: 10.1073/pnas.96.17.9803 Publication Date: 2002-07-26T14:41:48Z
ABSTRACT
TRAF5 [tumor necrosis factor (TNF) receptor-associated factor 5] is implicated in NF-κB and c-Jun NH2-terminal kinase/stress-activated protein kinase activation by members of the TNF receptor superfamily, including CD27, CD30, CD40, and lymphotoxin-β receptor. To investigate the functional role of TRAF5in vivo, we generated TRAF5-deficient mice by gene targeting. Activation of either NF-κB or c-Jun NH2-terminal kinase/stress-activated protein kinase by tumor necrosis factor, CD27, and CD40 was not abrogated intraf5−/−mice. However,traf5−/−B cells showed defects in proliferation and up-regulation of various surface molecules, including CD23, CD54, CD80, CD86, and Fas in response to CD40 stimulation. Moreover,in vitroIg production oftraf5−/−B cells stimulated with anti-CD40 plus IL-4 was reduced substantially. CD27-mediated costimulatory signal also was impaired intraf5−/−T cells. Collectively, these results demonstrate that TRAF5 is involved in CD40- and CD27-mediated signaling.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (34)
CITATIONS (148)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....